Shanghai, China — February 10, 2026 — Leads & Copy —Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will release its fourth quarter and full year 2025 financial results, along with recent corporate updates, on February 26, 2026, before the U.S. equity markets open.
Following the announcement, the company will host a conference call and webcast at 8:00 a.m. ET (9:00 p.m. HKT).
The live webcast can be accessed via the company’s website.
Advance registration is required for both the webcast and the dial-in conference call. The registration link for the webcast is https://edge.media-server.com/mmc/p/ftt8dzjp, and the registration link for dial-in is https://register-conf.media-server.com/register/BI3888301d591947ae8d0ccb041164c8e6.
Upon registering, participants will receive a confirmation email containing dial-in details. A replay will be available shortly after the call on the company’s website.
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is a biopharmaceutical company based in China and the United States. The company focuses on discovering, developing, and commercializing products that address unmet medical needs in oncology, immunology, neuroscience, and infectious disease.
The company’s goal is to positively impact human health.
For more information, visit www.zailaboratory.com or follow them at www.X.com/ZaiLab_Global.
Source: Zai Lab
